Literature DB >> 30571126

Unbinding Dynamics of Non-Nucleoside Inhibitors from HIV-1 Reverse Transcriptase.

Leela S Dodda1, Julian Tirado-Rives1, William L Jorgensen1.   

Abstract

Non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs), which bind to an allosteric site 10-15 Å from the polymerase active site, play a central role in anti-HIV chemotherapy. Though NNRTIs have been known for 30 years, the pathways by which they bind and unbind from HIV-RT have not been characterized. In crystal structures for complexes, three channels are found to extend from the NNRTI binding site to the exterior of the protein, while added mystery comes from the fact that the binding site is collapsed in the unliganded protein. To address this issue, metadynamics simulations have been performed to elucidate the unbinding of four NNRTIs from HIV-RT. A general and transferable collective variable defined by the distance between the center-of-mass (COM) of the binding pocket and COM of the ligand is used to follow the dynamics while minimizing the bias. The metadynamics also allows computation of the barriers to unbinding, which are compared with the observed potencies of the compounds in an antiviral assay.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30571126      PMCID: PMC6395492          DOI: 10.1021/acs.jpcb.8b10341

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  36 in total

1.  Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT.

Authors:  Lingling Shen; Jianhua Shen; Xiaomin Luo; Feng Cheng; Yechun Xu; Kaixian Chen; Edward Arnold; Jianping Ding; Hualiang Jiang
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

2.  Escaping free-energy minima.

Authors:  Alessandro Laio; Michele Parrinello
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

3.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

4.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

5.  Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Authors:  Juliana Ruiz-Caro; Aravind Basavapathruni; Joseph T Kim; Christopher M Bailey; Ligong Wang; Karen S Anderson; Andrew D Hamilton; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2005-11-17       Impact factor: 2.823

6.  Potential energy functions for atomic-level simulations of water and organic and biomolecular systems.

Authors:  William L Jorgensen; Julian Tirado-Rives
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

7.  Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase.

Authors:  Zhigang Zhou; Marcela Madrid; Jeffrey D Evanseck; Jeffry D Madura
Journal:  J Am Chem Soc       Date:  2005-12-14       Impact factor: 15.419

8.  Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Authors:  Vinay V Thakur; Joseph T Kim; Andrew D Hamilton; Christopher M Bailey; Robert A Domaoal; Ligong Wang; Karen S Anderson; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2006-08-22       Impact factor: 2.823

9.  Molecular dynamics of HIV-1 reverse transcriptase indicates increased flexibility upon DNA binding.

Authors:  M Madrid; J A Lukin; J D Madura; J Ding; E Arnold
Journal:  Proteins       Date:  2001-11-15

10.  Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations.

Authors:  Anthony Ivetac; J Andrew McCammon
Journal:  J Mol Biol       Date:  2009-03-24       Impact factor: 5.469

View more
  7 in total

Review 1.  Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance.

Authors:  Francesc Xavier Ruiz; Eddy Arnold
Journal:  Curr Opin Struct Biol       Date:  2020-01-11       Impact factor: 6.809

2.  Metadynamics as a Postprocessing Method for Virtual Screening with Application to the Pseudokinase Domain of JAK2.

Authors:  Kara J Cutrona; Ana S Newton; Stefan G Krimmer; Julian Tirado-Rives; William L Jorgensen
Journal:  J Chem Inf Model       Date:  2020-05-27       Impact factor: 4.956

Review 3.  Molecular dynamics of the viral life cycle: progress and prospects.

Authors:  Peter Eugene Jones; Carolina Pérez-Segura; Alexander J Bryer; Juan R Perilla; Jodi A Hadden-Perilla
Journal:  Curr Opin Virol       Date:  2021-08-28       Impact factor: 7.121

4.  Exploring the Binding Mechanism of a Supramolecular Tweezer CLR01 to 14-3-3σ Protein via Well-Tempered Metadynamics.

Authors:  Xin Zhou; Mingsong Shi; Xin Wang; Dingguo Xu
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

5.  Human endogenous retrovirus-K (HERV-K) reverse transcriptase (RT) structure and biochemistry reveals remarkable similarities to HIV-1 RT and opportunities for HERV-K-specific inhibition.

Authors:  Eric T Baldwin; Matthias Götte; Egor P Tchesnokov; Eddy Arnold; Margit Hagel; Charles Nichols; Pam Dossang; Marieke Lamers; Paul Wan; Stefan Steinbacher; Donna L Romero
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-30       Impact factor: 12.779

Review 6.  Collective variable discovery in the age of machine learning: reality, hype and everything in between.

Authors:  Soumendranath Bhakat
Journal:  RSC Adv       Date:  2022-09-02       Impact factor: 4.036

7.  Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Authors:  Kaijun Jin; Minjie Liu; Chunlin Zhuang; Erik De Clercq; Christophe Pannecouque; Ge Meng; Fener Chen
Journal:  Acta Pharm Sin B       Date:  2019-10-17       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.